Jay S. Skyler - May 3, 2024 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Jay S. Skyler
Stock symbol
SABS
Transactions as of
May 3, 2024
Transactions value $
$0
Form type
3
Date filed
5/14/2024, 05:00 PM
Previous filing
Jun 8, 2023
Next filing
Jun 7, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.